![](images/CAI_TOP1.jpg) |
|
![](images/Templates/Web_Layout_Home_27.jpg) |
|
|
![](images/Templates/Web_Layout_Home_29.jpg) |
![About Atlas](images/Templates/Web_Layout_Home_30.jpg) |
![](images/Templates/Web_Layout_Home_31.jpg) |
![](images/Templates/Web_Layout_Home_32.jpg) |
![](images/Templates/spacer.gif) |
![Reports](images/Templates/Web_Layout_Home_33.jpg) |
![](images/Templates/spacer.gif) |
![Related Links](images/Templates/Web_Layout_Home_34.jpg) |
![](images/Templates/spacer.gif) |
![](images/Templates/Web_Layout_Home_35.jpg) |
![](images/Templates/Web_Layout_Home_36.jpg) |
|
![](images/Templates/spacer.gif) |
![Register](images/Templates/Web_Layout_Home_38.jpg) |
![](images/Templates/spacer.gif) |
![Contact Us](images/Templates/Web_Layout_Home_39.jpg) |
![](images/Templates/spacer.gif) |
![](images/Templates/Web_Layout_Home_40.jpg) |
![](images/Templates/Web_Layout_Home_41.jpg) |
![](images/Templates/spacer.gif) |
![](images/Templates/Web_Layout_Home_42.jpg) |
![](images/Templates/spacer.gif) |
![](images/Templates/Web_Layout_Home_43.jpg) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
![](images/Templates/spacer.gif) |
|
Las compañías farmacéuticas en la India desarrollan con éxito medicamentos genéricos para el cáncer. Las muestras a España se pueden pedir en este enlace. |
Site maintained and updated by NCRP Staff, Coordinating Unit Bangalore © Copyright National Cancer Registry Programme 2010. All rights reserved.
|
|